Abstract:Gliomas, and in particular glioblastoma multiforme, are aggressive brain tumors characterized by a poor prognosis and high rates of recurrence. Current treatment strategies are based on open surgery, chemotherapy (temozolomide) and radiotherapy. However, none of these treatments, alone or in combination, are considered effective in managing this devastating disease, resulting in a median survival time of less than 15 months. The efficiency of chemotherapy is mainly compromised by the blood-brain barrier (BBB) that selectively inhibits drugs from infiltrating into the tumor mass. Cancer stem cells (CSCs), with their unique biology and their resistance to both radio- and chemotherapy, compound tumor aggressiveness and increase the chances of treatment failure. Therefore, more effective targeted therapeutic regimens are urgently required. In this article, some well-recognized biological features and biomarkers of this specific subgroup of tumor cells are profiled and new strategies and technologies in nanomedicine that explicitly target CSCs, after circumventing the BBB, are detailed. Major achievements in the development of nanotherapies, such as organic poly(propylene glycol) and poly(ethylene glycol) or inorganic (iron and gold) nanoparticles that can be conjugated to metal ions, liposomes, dendrimers and polymeric micelles, form the main scope of this summary. Moreover, novel biological strategies focused on manipulating gene expression (small interfering RNA and clustered regularly interspaced short palindromic repeats [CRISPR]/CRISPR associated protein 9 [Cas 9] technologies) for cancer therapy are also analyzed. The aim of this review is to analyze the gap between CSC biology and the development of targeted therapies. A better understanding of CSC properties could result in the development of precise nanotherapies to fulfill unmet clinical needs.

Current Non-Metal Nanoparticle-Based Therapeutic Approaches for Glioblastoma Treatment

Targeted Theranostic Nanoparticles for Brain Tumor Treatment

Targeting the undruggable in glioblastoma using nano-based intracellular drug delivery

Poly(ethylene Glycol) Based Nanotubes for Tuneable Drug Delivery to Glioblastoma Multiforme

Designing Gold Nanoparticles for Precise Glioma Treatment: Challenges and Alternatives

Polymer nanocarriers for targeted local delivery of agents in treating brain tumors

Biomimetic nanoparticle-driven strategies for targeted drug delivery in glioblastoma

Potential of Nanocarrier-Associated Approaches for Better Therapeutic Intervention in the Management of Glioblastoma

Progress of nanoparticle drug delivery system for the treatment of glioma

Lipid-based nanoparticles to address the limitations of GBM therapy by overcoming the blood-brain barrier, targeting glioblastoma stem cells, and counteracting the immunosuppressive tumor microenvironment

Targeted Nanotechnology in Glioblastoma Multiforme

Contemporary strategies in glioblastoma therapy: Recent developments and innovations

Nanotherapeutic treatment of the invasive glioblastoma tumor microenvironment

Nanoparticles for efficient drug delivery and drug resistance in glioma: New perspectives

Targeted Polymeric Nanoparticles as a Strategy for the Treatment of Glioblastoma: A Review

Advances in nanotechnology for the treatment of GBM

Solid Lipid Nanoparticles and Nanostructured Lipid Carriers as Smart Drug Delivery Systems in the Treatment of Glioblastoma Multiforme

Cancer cell membrane-camouflaged biomimetic nanoparticles for enhancing chemo-radiation therapy efficacy in glioma

How Nanotherapeutic Platforms Play a Key Role in Glioma? A Comprehensive Review of Literature

Nanoparticles: a New Approach to the Diagnosis and Treatment of Cerebral Glial Tumours

Nanoparticles: Novel vehicles in treatment of Glioblastoma